Arterial Stiffness and Coronary Artery Disease - European Medical Journal
×

Browse

Arterial Stiffness and Coronary Artery Disease

| Download as | PDF
12 Mins
Authors:
*Hack-Lyoung Kim
Disclosure:

The author has declared no conflicts of interest.

Received:
15.02.16
Accepted:
22.06.16
Citation
EMJ Cardiol. ;4[1]:84-89.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Abstract

Although there have been marked improvements in both diagnostic and therapeutic interventions over several decades, coronary artery disease (CAD) remains the leading cause of death worldwide. Intensive modification of classic risk factors such as hypertension, diabetes mellitus, dyslipidaemia, and cigarette smoking has significantly reduced the development of CAD. The high prevalence of residual cardiovascular events does however require improvements in identification and risk stratification strategies. In this context, arterial stiffness, which reflects arterial ageing, damage, and arteriosclerosis has emerged as an important risk factor for cardiovascular disease. The measurements of arterial stiffness are easy to make using several non-invasive methods such as pulse wave velocity. The clinical utility of the measures has been validated in many prior studies. Recent evidence has suggested that the measures of arterial stiffness are correlated with the presence and extent of CAD. More importantly, increased arterial stiffness is an independent predictor of CAD-related morbidity and mortality beyond classic risk factors. Considering its non-invasiveness, simplicity, and reliability, arterial stiffness could serve as a useful marker of CAD and help identify high-risk patients who may benefit from more aggressive management.

INTRODUCTION

Coronary artery disease (CAD) remains one of the leading causes of death and disability worldwide.1,2 The underlying pathophysiology of most CAD is atherosclerosis, a complex process governed by multiple factors. Classic risk factors such as hypertension, diabetes mellitus, dyslipidaemia, cigarette smoking, and obesity, have been well-documented as significant contributors to the development of atherosclerosis and CAD.3,4 In fact, aggressive treatment of these factors has significantly reduced the risk of future cardiovascular events.5 By the strength of evidence supporting their role in the pathogenesis of CAD, these classic risk factors have usually been a primary therapeutic target in patients with known or suspected CAD. Indeed, with many efforts focussed on these classic risk factors, there has been significant progress and improvement in prevention, diagnosis, and therapy however, the burden of CAD is still substantial. It is now generally accepted that classic risk factors cannot fully explain the increasing burden of CAD and that more than 50% of patients with CAD do not have any of these risk factors.6,7 Although several risk prediction models using a combination of individual classic risk factors have been suggested, they have a low diagnostic yield in the prediction of future cardiovascular events, depending on population and ethnicity.8,9 These findings suggest that other factors are clearly involved and raise the need for another tool to improve prevention and management of CAD beyond classic risk factors.

Arterial stiffness is accelerated by ageing, arterial damage, and arteriosclerosis.10 Arterial stiffness is an important reflection of degeneration of the arterial wall as a consequence of repetitive cyclic stress.10 From the pathologic point of view, arterial stiffening is characterised by the loss of elastic fibres and increases collagen deposition and cross-linking within arterial walls.10 Emerging evidence suggests that arterial stiffness is one of the earliest detectable signs of functional and structural changes in the arterial wall.11,12 The measurement of arterial stiffness could be advantageous in early detection and prevention of vascular disease. More importantly, arterial stiffness can predict adverse cardiovascular events beyond classic risk factors, in patient groups with different diseases13-16 and in the general population.17,18 Recent studies have reported that arterial stiffness is associated with the presence and extent of CAD19-23 and cardiovascular outcomes.13,14,17,24 Special attention has been focussed on the measurement of arterial stiffness as a reliable and useful non-invasive tool to improve detection and risk stratification of patients with CAD. The present review summarises how to assess arterial stiffness and provides clinical evidence for the detection of CAD and the prediction of CAD-related outcomes based on arterial stiffness.

MEASUREMENTS OF ARTERIAL STIFFNESS

Pulse Wave Velocity

Arterial stiffness can be assessed using several non-invasive and invasive methods. Among them, pulse wave velocity (PWV) is the most widely and frequently used tool to quantify arterial stiffness, because its measurement is non-invasive, simple, and reproducible.10,12 Of note, there has been much data indicating the clinical values of PWV in the prediction of cardiovascular events.13-15,25,26 PWV is the measure of the speed of the arterial pressure waves travelling along the aorta and large arteries. Therefore, PWV can be determined by dividing distance with transit time of pressure waveforms at the two recording sites.12 PWV is inversely correlated with arterial compliance; it is faster in a more stiffened artery. According to arteries measured, there are several types of PWV. Carotid-femoral PWV (cfPWV), which is made by recording pressure waveforms at the carotid artery followed by the femoral artery, is most validated, and has been considered a reference standard technique to assess arterial stiffness.27 However, the wide use of cfPWV in clinical practice is hindered by the need for technical skills during the carotid and femoral pulse acquisition. In addition to this, cfPWV measurement causes some discomfort to subjects and is time-consuming. To overcome these drawbacks of cfPWV, the newly developed and simpler measurement, brachial-ankle PWV (baPWV), has been used in research and clinical fields. The baPWV measurement does not require technical expertise and it can be done by simply wrapping blood pressure cuffs around the four extremities.28 Therefore, the measurement of baPWV is simple and timesaving. Furthermore, baPWV is well-correlated with cfPWV29 and invasive parameters,28 and the diagnostic and prognostic values of baPWV have been proven in many clinical studies,20,22,24,28,30-32 and in a meta-analysis.26 There has been some criticism that baPWV cannot reflect pure central arterial stiffness because it includes a much more peripheral component.33 However, considering its simplicity and clinical values, baPWV is expected to be more widely used in clinical practice, especially for the purpose of mass screening.

Pulse Pressure and Augmentation Index

Pulse pressure (PP) is defined as the difference between systolic blood pressure and diastolic blood pressure. Augmentation index (Alx) is defined as augmented pressure divided by PP. Elevated PP and Alx are regarded as a manifestation of increased arterial stiffness, although Alx is a more complex measure of wave forms propagated during systole with the reflected waves from peripheral arteries. In a stiffened artery, a reflected wave from the periphery returns faster and arrives earlier at the central aorta during myocardial systole which increases PP and the pressure at the late systolic phase (equalling augmentation pressure). PP and Alx are closely related to target organ damage, and they are important predictors of cardiovascular events.18,34 However, it should be considered that PP and Alx are potentially confounded by factors related to cardiac function such as heart rate and stroke volume.35 In addition, Alx has been found to have limited value as a marker of arterial stiffness in older individuals, particularly after 60 years of age.36

Central Aortic Pressure

An invasively measured aortic pulsatile component is considered the gold standard for assessing central arterial stiffness. Anatomically, the central aorta is closer to the brain, heart, and kidneys, therefore the impact of aortic pulsatile stress is more pronounced to these vital organs than that of peripheral artery.37 It has been reported that the stiffness of the central elastic artery is more strongly correlated with cardiovascular and all-cause mortality than that of the peripheral artery.37 Indeed, intra-aortic haemodynamic parameters, as recorded during invasive coronary angiography (ICA), have been shown to be a valuable measure of aortic stiffness.37-40 Therefore, measurement of central aortic pressure has been emphasised.37 However, difficulty in performing this invasive examination limits its use in clinical practice. Although current non-invasive techniques can estimate central pressure by analysing radial or carotid pulse waves using a mathematical relationship to peripheral pressure,41,42 the possibility of calculation error is not negligible.43

Other Modalities

Magnetic resonance imaging and echocardiography can assess arterial stiffness of deep large arteries such as the aorta.12,44 However, these methods are expensive, time-consuming, and technically difficult. Therefore, they are impractical for wide clinical use.

ASSOCIATION BETWEEN ARTERIAL STIFFNESS AND THE PRESENCE AND EXTENT OF CORONARY ARTERY DISEASE

Prior studies have documented a direct relationship between arterial stiffness and the presence or extent of CAD. Recently, our study group investigated 470 patients who underwent both baPWV measurement and coronary computed tomography angiography (CCTA), and showed good correlations between baPWV and the CCTA parameters of CAD extent.20 Xiong et al.22 also used baPWV as a measure of arterial stiffness in 321 patients and reported an independent association between baPWV and CAD severity as assessed by ICA and SYNTAX (SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery) score. Alarhabi et al.19 demonstrated in a study of 92 patients undergoing ICA, that arterial stiffness measured through cfPWV is independently associated with multivessel disease. In accordance with these findings, Lim et al.21 performed a prospective study of 326 consecutive patients undergoing ICA and showed that cfPWV was significantly associated with the severity of CAD, expressed as one, two, or three-vessel disease. Invasive measurement of aortic pressure is feasible and parameters of central haemodynamics have provided useful information in patients undergoing ICA. A study by Nakayama et al.39 has indicated the usefulness of invasively measured pulsatility index of the ascending aorta as a predictor of in-stent restenosis after percutaneous transluminal coronary angioplasty. Philippe et al.23 invasively measured aortic PP in 99 patients undergoing ICA and showed that aortic PP is independently correlated with the CAD extent. Jankowski et al.40 measured aortic pulsatile components in 423 consecutive patients undergoing ICA and also demonstrated that aortic PP, fractional PP, and pulsatility index are risk factors for three-vessel disease.

ARTERIAL STIFFNESS AND CORONARY ARTERY DISEASE-RELATED OUTCOMES

Recent longitudinal studies have suggested that arterial stiffness is an important predictor for CAD-related morbidity and mortality in patients with different diseases as well as in the general population. In those studies, the prognostic value of arterial stiffness persists even after controlling for potential confounding effects by classic risk factors such as age, hypertension, diabetes mellitus, and dyslipidaemia. Boutouyrie et al.14 measured cfPWV in 1,045 hypertensive subjects and showed that cfPWV is significantly associated with the occurrence of coronary events during a mean follow-up of 5.7 years even after adjustment for the Framingham Risk Score or classic risk factors. Blacher et al.13 investigated 241 patients with end-stage renal disease undergoing haemodialysis, and reported that increased aortic stiffness measured by aortic PWV is a strong independent predictor for all-cause and cardiovascular mortality. Another study of 2,231 patients with acute myocardial infarction accompanied by left ventricular (LV) dysfunction over a 42-month follow-up period, documented that there is a close link between PP and subsequent cardiovascular events.16 Kim et al.15 studied 1,765 patients with acute ischaemic stroke during a mean follow-up period of 3.3 years and showed an independent association between baPWV and all-cause and vascular death. In a recently published article, with 2 years of clinical follow-up in 1,126 subjects >80 years old, it has been found that increases in carotid and brachial PP amplification is associated with reduction of total mortality and cardiovascular events.18 A more recent study performed by our study group, involving 350 subjects undergoing myocardial perfusion imaging, showed that baPWV provided additional prognostic value to classic risk factors and myocardial perfusion imaging in predicting cardiovascular events during the 441 days of clinical follow-up.32 The value of aortic PWV in predicting future cardiovascular events and all-cause mortality was also proven in a meta-analysis of 17 longitudinal studies of 15,877 subjects with a mean follow-up period of 7.7 years.25 The authors indicated that the risk of cardiovascular events and cardiovascular mortality is more than 2-times higher in subjects with high aortic PWV than in those with low aortic PWV.25

POSSIBLE MECHANISMS UNDERLYING THE LINK BETWEEN ARTERIAL STIFFNESS AND CORONARY ARTERY DISEASE

Precise mechanisms underlying the link between arterial stiffness and CAD have not been clearly established. Multiple complicated factors may be involved and interact with each other to a greater or lesser extent. There are however several accepted explanations of the association between increased arterial stiffness and CAD. First, increased arterial stiffness is the main cause of premature return of reflected waves in the late systole which is associated with increased PP and the afterload of LV. Increased LV load subsequently increases in LV mass and oxygen demand.45 In addition to increased load on the LV, increased arterial stiffness decreases diastolic pressure which is closely linked to impaired coronary perfusion and myocardial ischaemia.46 These unfavourable pathophysiological changes may lead to the progression of coronary atherosclerosis. Considering the fact that PP increases significantly only after the fifth decade,47 it is a natural hypothesis that the role of arterial stiffness in the evaluation of CAD is more valuable, especially in elderly people. Secondly, arterial stiffness itself reflects the burden of underlying systemic atherosclerosis and the presence of end-organ damage, both of which are associated with CAD and CAD related outcomes. Thirdly, arterial stiffness changes mainly with age.48 The prevalence of traditional risk factors for CAD is also increased with age. Therefore, arterial stiffening and CAD are considered to share many risk factors, including ageing, hypertension, diabetes mellitus, dyslipidaemia, and smoking.10,12 These risk factors for atherosclerosis may have a worse impact on both arterial stiffening and the development and progression of CAD. For these reasons, it can be postulated that the association between increased arterial stiffness and CAD is incidental. Accordingly, the clinical importance of arterial stiffness is frequently underestimated in patients with CAD because arterial stiffness changes with age. However, considering that the prognostic value of arterial stiffness does not change even after adjustment for age and other classic risk factors,13-18 it is evident that arterial stiffness is an independent predictor for future atherosclerotic cardiovascular events beyond classic risk factors. Finally, recent evidence has shown that inflammation can affect arterial stiffness.49 Given that chronic systemic inflammation is also closely related to cardiovascular risk,50 the association between increased arterial stiffness and CAD may be at least partially mediated by inflammation.

MANAGEMENT STRATEGY REDUCING ARTERIAL STIFFNESS

Several prior studies have shown that some pharmacological and non-pharmacological interventions may improve arterial stiffness.  Although the degree of arterial stiffness reduction is different according to drug classes, doses, and treatment duration angiotensin converting enzyme inhibitor has been shown to be the most effective drug in reducing both peripheral and central arterial stiffness in long-term treatment.12,37,51 Recent studies have also reported that non-pharmacological interventions, including aerobic exercise training and continuous positive airway pressure in patients with sleep apnoea, improve arterial stiffness.12 However, whether the reduction of arterial stiffness by these pharmacological and non-pharmacological interventions can lead to a favourable clinical outcome remains to be determined in further studies.

CLINICAL IMPLICATIONS

Although there has been a marked improvement in both diagnostic and therapeutic interventions over several decades, CAD remains the leading cause of death worldwide.1,2 Intensive modification of classic risk factors has significantly reduced the development of CAD, however the high residual prevalence of cardiovascular events requires further improvements in identification and risk stratification strategies. Recent cardiovascular risk scoring strategies are not sufficient to identify patients at a high risk of CAD.8,9 Accurate assessment of CAD and its complications remains problematic for clinicians. Arterial stiffening is one of the earliest manifestations of vascular damage and atherosclerosis. However, it is difficult to recognise such subclinical changes in routine medical practice. Simple and non-invasive measurement of arterial stiffness, such as PWV, can detect functional and structural changes in arterial wall even in early stages. As mentioned above, many cross-sectional and longitudinal studies have confirmed that arterial stiffness is closely related to CAD and CAD-related outcomes. Therefore, arterial stiffness measurement could serve as an important tool to identify patients at a high risk of CAD. Improved ability to identify such patients would lead to better risk stratification and more effective preventive therapy. Additionally, arterial stiffness can be a target or monitoring tool for therapeutic intervention.12,35 Appropriate medications reducing arterial stiffness may offer potential advantages in the management of patients at a high risk of CAD.

CONCLUSIONS

The measures of arterial stiffness are well-correlated with the presence and extent of CAD. More importantly, arterial stiffness is an independent predictor for CAD-related mortality and morbidity in various populations which are beyond prediction, based on classic risk factors. Considering its non-invasiveness, simplicity, and reliability, arterial stiffness could serve as a useful marker of CAD and help detect high-risk patients who may benefit from more aggressive management.

References
Lopez AD et al. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet. 2006;367(9524):1747-57. Moran AE et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129(14):1493-501. Khot UN et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290(7):898-904. Hammoudeh AJ et al. Prevalence of conventional risk factors in Jordanians with coronary heart disease: the Jordan Hyperlipidemia and Related Targets Study (JoHARTS). Int J Cardiol. 2006;110(2):179-83. Lewington S et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-13. Futterman LG, Lemberg L. Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors. Am J Crit Care. 1998;7(3):240-4. Hennekens CH. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation. 1998;97(11):1095-102. Brindle P et al. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: A systematic review. Heart. 2006;92(12):1752-9. Liu J et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004;291(21):2591-9. Lee HY, Oh BH. Aging and arterial stiffness. Circ J. 2010;74(11):2257-62. Cohn JN et al. Surrogate markers for cardiovascular disease: Functional markers. Circulation. 2004;109(25 Supp 1):IV31-46. Cavalcante JL et al. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol. 2011;57(14):1511-22. Blacher J et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99(18):2434-9. Boutouyrie P et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study. Hypertension. 2002;39(1):10-5. Kim J et al. Brachial-ankle pulse wave velocity is a strong predictor for mortality in patients with acute stroke. Hypertension. 2014;64(2):240-6. Mitchell GF et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. Circulation. 1997;96(12):4254-60. Roman MJ et al. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol. 2009;54(18):1730-4. Benetos A et al. Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE (Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population) study. J Am Coll Cardiol. 2012;60(16):1503-11. Alarhabi AY et al. Pulse wave velocity as a marker of severity of coronary artery disease. J Clin Hypertens (Greenwich). 2009;11(1):17-21. Kim HL et al. The association of brachial-ankle pulse wave velocity with coronary artery disease evaluated by coronary computed tomography angiography. PLoS One. 2015;10(4):e0123164. Lim HE et al. Aortic pulse wave velocity as an independent marker of coronary artery disease. Blood Press. 2004;13(6):369-75. Xiong Z et al. Relationship between arterial stiffness assessed by brachial-ankle pulse wave velocity and coronary artery disease severity assessed by the SYNTAX score. J Atherosclr Thromb. 2012;19(11):970-6. Philippe F et al. Aortic pulse pressure and extent of coronary artery disease in percutaneous transluminal coronary angioplasty candidates. Am J Hypertens. 2002;15(8):672-7. Yambe M et al. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res. 2004;27(9):625-31. Vlachopoulos C et al. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318-27. Vlachopoulos C et al. Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension. 2012;60(2):556-62. Mancia G et al. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood press. 2014;23(1):3-16. Yamashina A et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 2002;25(3):359-64. Tanaka H et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens. 2009;27(10):2022-7. Yu WC et al. Brachial-ankle vs carotid-femoral pulse wave velocity as a determinant of cardiovascular structure and function. J Hum Hypertens. 2008;22(1):24-31. Kim HL et al. Independent association between brachial-ankle pulse wave velocity and global longitudinal strain of left ventricle. Int J Cardiovasc Imaging. 2015;31(8):1563-70. Lee HS et al. Incremental Prognostic Value of Brachial-Ankle Pulse Wave Velocity to Single-Photon Emission Computed Tomography in Patients with Suspected Coronary Artery Disease. J Atheroscler Thromb. 2015;22(10):1040-50. Sugawara J, Tanaka H. Brachial-Ankle Pulse Wave Velocity: Myths, Misconceptions, and Realities. Pulse (Basel). 2015;3(2):106-13. Franklin SS et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation. 2001;103(9):1245-9. Dart AM, Kingwell BA. Pulse pressure-a review of mechanisms and clinical relevance. J Am Coll Cardiol. 2001;37(4):975-84. McEniery CM et al. Normal vascular aging: Differential effects on wave reflection and aortic pulse wave velocity: The Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46(9):1753-60. McEniery CM et al. Central blood pressure: Current evidence and clinical importance. Euro Heart J. 2014;35(26):1719-25. Kim HL et al. Association between invasively measured central aortic pressure and left ventricular diastolic function in patients undergoing coronary angiography. Am J Hypertens. 2015;28(3):393-400. Nakayama Y et al. Jankowski P et al. Ascending aortic, but not brachial blood pressure-derived indices are related to coronary atherosclerosis. Circulation. 2000;101(5):470-2. Jankowski P et al. Ascending aortic, but not brachial blood pressure-derived indices are related to coronary atherosclerosis. Atherosclerosis. 2004;176(1):151-5. Sharman JE et al. Validation of a generalized transfer function to noninvasively derive central blood pressure during exercise. Hypertension. 2006;47(6):1203-8. Chen CH et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997;95(7):1827-36. Smulyan H et al. Clinical utility of aortic pulses and pressures calculated from applanated radial-artery pulses. Hypertension. 2003;42(2):150-5. Redheuil A et al. Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans. Hypertension. 2010;55(2):319-26. Boutouyrie P et al. Common carotid artery stiffness and patterns of left ventricular hypertrophy in hypertensive patients. Hypertension. 1995;25(4 Pt 1):651-9. Watanabe H et al. Decreased aortic compliance aggravates subendocardial ischaemia in dogs with stenosed coronary artery. Cardiovasc Res. 1992;26(12):1212-8. Franklin SS et al. Hemodynamic patterns of age-related changes in blood pressure: The Framingham Heart Study. Circulation. 1997;96(1):308-15. Lee CS et al. Ethnic coefficients for glomerular filtration rate estimation by the Modification of Diet in Renal Disease study equations in the Korean population. J Korean Med Sci. 2010;25(11):1616-25. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension. 2005;46(5):1118-22. Kaptoge S et al.; Emerging Risk Factors Collaboration. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367(14):1310-20. Topouchian J et al.; Arterial stiffness and pharmacological interventions – The Transcend Arterial StiffNess Substudy (TRANS study). Vasc Health Risk Manag. 2007;3(4):381-7.